Impact of High Altitude on Cardiovascular Health: Current Perspectives

References

• Cohen JE, Small C. Hypsographic demography: the distribution of human population by altitude. Proc Natl Acad Sci U S A. 1998;95(24):14009–14014. doi:10.1073/pnas.95.24.14009
   PubMed Web of Science ®Google Scholar
• Burtscher M, Bachmann O, Hatzl T, et al. Cardiopulmonary and metabolic responses in healthy elderly humans during a 1-week hiking programme at high altitude. Eur J Appl Physiol. 2001;84(5):379–386. doi:10.1007/s004210100393
   PubMed Web of Science ®Google Scholar
• Netzer N, Strohl K, Faulhaber M, Gatterer H, Burtscher M. Hypoxia-related altitude illnesses. J Travel Med. 2013;20(4):247–255. doi:10.1111/jtm.12017
   PubMed Web of Science ®Google Scholar
• Burtscher M, Gatterer H, Burtscher J, Mairbäurl H. Extreme terrestrial environments: life in thermal stress and hypoxia. a narrative review. Front Physiol. 2018;9:572. doi:10.3389/fphys.2018.00572
   PubMed Web of Science ®Google Scholar
• Moore LG. Human genetic adaptation to high altitude. High Alt Med Biol. 2001;2(2):257–279. doi:10.1089/152702901750265341
   PubMed Web of Science ®Google Scholar
• Winslow RM, Monge C. Hypoxia, Polycythemia, and Chronic Mountain Sickness. Johns Hopkins Univ.Press; 1987.
   Google Scholar
• Hackett PH, Roach RC. High-altitude illness. New Engl J Med. 2001;345(2):107–114. doi:10.1056/NEJM200107123450206
   PubMed Web of Science ®Google Scholar
• Basnyat B, Murdoch DR. High-altitude illness. Lancet. 2003;361(9373):1967–1974. doi:10.1016/S0140-6736(03)13591-X
   PubMed Web of Science ®Google Scholar
• West JB. High living: lessons from extreme altitude. The 1984 J. Burns Amberson lecture. Am Rev Respir Dis. 1984;130(5):917–923. doi:10.1164/arrd.1984.130.5.917
   PubMedGoogle Scholar
• Gazal S, Espinoza JR, Austerlitz F, et al. The genetic architecture of chronic mountain sickness in peru. Front Genet. 2019;10:690. doi:10.3389/fgene.2019.00690
   PubMed Web of Science ®Google Scholar
• West JB. Acclimatization and tolerance to extreme altitude. J Wilderness Med. 1993;4(1):17–26. doi:10.1580/0953-9859-4.1.17
   PubMedGoogle Scholar
• Finch CE, Tanzi RE. Genetics of aging. Science. 1997;278(5337):407–411. doi:10.1126/science.278.5337.407
   PubMed Web of Science ®Google Scholar
• Nilsson PM. Genetic and environmental determinants of early vascular ageing (EVA). Curr Vasc Pharmacol. 2012;10(6):700–701. doi:10.2174/157016112803520981
   PubMed Web of Science ®Google Scholar
• Bunker A, Wildenhain J, Vandenbergh A, et al. Effects of air temperature on climate-sensitive mortality and morbidity outcomes in the elderly; a systematic review and meta-analysis of epidemiological evidence. EBioMedicine. 2016;6:258–268. doi:10.1016/j.ebiom.2016.02.034
   PubMed Web of Science ®Google Scholar
• Crawford JE, Amaru R, Song J, et al. Natural selection on genes related to cardiovascular health in high-altitude adapted andeans. Am J Hum Genet. 2017;101(5):752–767. doi:10.1016/j.ajhg.2017.09.023
   PubMed Web of Science ®Google Scholar
• Burtscher M. Effects of living at higher altitudes on mortality: a narrative review. Aging Dis. 2014;5(4):274. doi:10.14336/AD.2014.0500274
   PubMed Web of Science ®Google Scholar
• Ezzati M, Horwitz ME, Thomas DS, et al. Altitude, life expectancy and mortality from ischaemic heart disease, stroke, COPD and cancers: national population-based analysis of US counties. J Epidemiol Community Health. 2012;66(7):e17–e17. doi:10.1136/jech.2010.112938
   PubMed Web of Science ®Google Scholar
• Faeh D, Gutzwiller F, Bopp M, Group SNCS. Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009;120(6):495. doi:10.1161/CIRCULATIONAHA.108.819250
   PubMed Web of Science ®Google Scholar
• Burtscher M, Ponchia A. The risk of cardiovascular events during leisure time activities at altitude. Prog Cardiovasc Dis. 2010;52(6):507–511. doi:10.1016/j.pcad.2010.02.008
   PubMed Web of Science ®Google Scholar
• Bärtsch P, Swenson ER. Clinical practice: acute high-altitude illnesses. N Engl J Med. 2013;368(24):2294–2302. doi:10.1056/NEJMcp1214870
   PubMed Web of Science ®Google Scholar
• Richalet J-P, Lhuissier FJ. Aging, tolerance to high altitude, and cardiorespiratory response to hypoxia. High Alt Med Biol. 2015;16(2):117–124. doi:10.1089/ham.2015.0030
   PubMed Web of Science ®Google Scholar
• Mallet RT, Manukhina EB, Ruelas SS, Caffrey JL, Downey HF. Cardioprotection by intermittent hypoxia conditioning: evidence, mechanisms, and therapeutic potential. Am J Physiol Heart Circ Physiol. 2018;315(2):H216–H232. doi:10.1152/ajpheart.00060.2018
   PubMed Web of Science ®Google Scholar
• Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993–2002. BMC Cancer. 2006;6:264. doi:10.1186/1471-2407-6-264
   PubMed Web of Science ®Google Scholar
• Burtscher M. Lower mortality rates in those living at moderate altitude. Aging (Albany NY). 2016;8(10):2603–2604. doi:10.18632/aging.101057
   PubMedGoogle Scholar
• Thielke S, Slatore CG, Banks WA. Association between Alzheimer dementia mortality rate and altitude in California counties. JAMA Psychiatry. 2015;72(12):1253–1254. doi:10.1001/jamapsychiatry.2015.1852
   PubMed Web of Science ®Google Scholar
• Moore LG, Rohr AL, Maisenbach JK, Reeves JT. Emphysema mortality is increased in Colorado residents at high altitude. Am Rev Respir Dis. 1982;126(2):225–228.
   PubMed Web of Science ®Google Scholar
• Schobersberger W, Schmid P, Lechleitner M, et al. Austrian Moderate Altitude Study 2000 (AMAS 2000). The effects of moderate altitude (1700 m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur J Appl Physiol. 2003;88(6):506–514. doi:10.1007/s00421-002-0736-8
   PubMed Web of Science ®Google Scholar
• West JB. Highest inhabitants in the world. Nature. 1986;324(6097):517. doi:10.1038/324517a0
   PubMed Web of Science ®Google Scholar
• Song C, Chongsuvivatwong V, Zhu Luo Bu O, Sang Zhuo Ma B, Sriplung H. Relationship between hypertension and geographic altitude: a cross-sectional survey among residents in Tibet. J Int Med Res. 2020;48(2):300060520903645. doi:10.1177/0300060520903645
   PubMed Web of Science ®Google Scholar
• Mingji C, Onakpoya IJ, Perera R, Ward AM, Heneghan CJ. Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review. Heart. 2015;101(13):1054–1060. doi:10.1136/heartjnl-2014-307158
   PubMed Web of Science ®Google Scholar
• Aryal N, Weatherall M, Bhatta YK, Mann S. Blood pressure and hypertension in adults permanently living at high altitude: a systematic review and meta-analysis. High Alt Med Biol. 2016;17(3):185–193. doi:10.1089/ham.2015.0118
   PubMed Web of Science ®Google Scholar
• Beall CM. Tibetan and Andean patterns of adaptation to high-altitude hypoxia. Hum Biol. 2000;72(1):201–228.
   PubMed Web of Science ®Google Scholar
• Narvaez-Guerra O, Herrera-Enriquez K, Medina-Lezama J, Chirinos JA. Systemic hypertension at high altitude. Hypertension. 2018;72(3):567–578. doi:10.1161/HYPERTENSIONAHA.118.11140
   PubMed Web of Science ®Google Scholar
• Bilo G, Acone L, Anza-Ramírez C, et al. Office and ambulatory arterial hypertension in highlanders: HIGHCARE-ANDES Highlanders Study. Hypertension. 2020;76(6):1962–1970. doi:10.1161/HYPERTENSIONAHA.120.16010
   PubMed Web of Science ®Google Scholar
• Sherpa LY, Deji SH. Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet. High Alt Med Biol. 2011;12(1):57–63. doi:10.1089/ham.2010.1050
   PubMed Web of Science ®Google Scholar
• Deng B, Luo T, Huang Y, Shen T, Ma J. Prevalence and determinants of hyperlipidemia in moderate altitude areas of the Yunnan-Kweichow plateau in Southwestern China. High Alt Med Biol. 2012;13(1):13–21. doi:10.1089/ham.2011.1037
   PubMed Web of Science ®Google Scholar
• Lopez-Pascual A, Arévalo J, Martínez JA, González-Muniesa P. Inverse association between metabolic syndrome and altitude: a cross-sectional study in an adult population of ecuador. Front Endocrinol (Lausanne). 2018;9:658. doi:10.3389/fendo.2018.00658
   PubMed Web of Science ®Google Scholar
• Rühli FJ, Henneberg M, Schaer DJ, Imhof A, Schleiffenbaum B, Woitek U. Determinants of inter-individual cholesterol level variation in an unbiased young male sample. Swiss Med Wkly. 2008;138(19–20):286–291.
   PubMed Web of Science ®Google Scholar
• Woolcott OO, Castillo OA, Gutierrez C, Elashoff RM, Stefanovski D, Bergman RN. Inverse association between diabetes and altitude: a cross-sectional study in the adult population of the United States. Obesity (Silver Spring). 2014;22(9):2080–2090. doi:10.1002/oby.20800
   PubMed Web of Science ®Google Scholar
• Okumiya K, Sakamoto R, Ishimoto Y, et al. Glucose intolerance associated with hypoxia in people living at high altitudes in the Tibetan highland. BMJ Open. 2016;6(2):e009728. doi:10.1136/bmjopen-2015-009728
   PubMed Web of Science ®Google Scholar
• Woolcott OO, Gutierrez C, Castillo OA, Elashoff RM, Stefanovski D, Bergman RN. Inverse association between altitude and obesity: a prevalence study among andean and low-altitude adult individuals of Peru. Obesity (Silver Spring). 2016;24(4):929–937. doi:10.1002/oby.21401
   PubMed Web of Science ®Google Scholar
• Leon-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Bio. 2005;6:147–157. doi:10.1089/ham.2005.6.147
   PubMed Web of Science ®Google Scholar
• Villafuerte FC, Corante N. Chronic mountain sickness: clinical aspects, etiology, management, and treatment. High Alt Med Biol. 2016;17(2):61–69. doi:10.1089/ham.2016.0031
   PubMed Web of Science ®Google Scholar
• Virues-Ortega J, Hogan AM, Baya-Botti A, et al. Survival and mortality in older adults living at high altitude in Bolivia: a preliminary report. J Am Geriatr Soc. 2009;57(10):1955–1956. doi:10.1111/j.1532-5415.2009.02468.x
   PubMed Web of Science ®Google Scholar
• Burtscher M, Hefti U, Hefti-Pichler J. High-altitude illnesses: old stories and new insights into the pathophysiology, treatment and prevention. Sports Med Health Sci. doi:10.1016/j.smhs.2021.04.001
   Google Scholar
• Mairer K, Wille M, Burtscher M. The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps. High Alt Med Biol. 2010;11(4):343–348. doi:10.1089/ham.2010.1039
   PubMed Web of Science ®Google Scholar
• Li X, Tao F, You H, Pei T, Gao Y. Factors associated with acute mountain sickness in young Chinese men on entering highland areas. Asia Pac J Public Health. 2015;27(2):NP116–31. doi:10.1177/1010539511427956
   PubMed Web of Science ®Google Scholar
• Richalet JP, Larmignat P, Poitrine E, Letournel M, Canouï-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(2):192–198. doi:10.1164/rccm.201108-1396OC
   PubMed Web of Science ®Google Scholar
• Wu TY, Ding SQ, Liu JL, et al. Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad. High Alt Med Biol. 2007;8(2):88–107. doi:10.1089/ham.2007.1015
   PubMed Web of Science ®Google Scholar
• Jayaswal R, Sivadas P, Mishra SS. Health and performance of military personnel in cold climatic environment of the western Himalayas. Med J Armed Forces India. 2001;57(4):322–325. doi:10.1016/S0377-1237(01)80014-9
   PubMedGoogle Scholar
• Marshall JM. Chemoreceptors and cardiovascular control in acute and chronic systemic hypoxia. Braz J Med Biol Res. 1998;31(7):863–888. doi:10.1590/s0100-879x1998000700002
   PubMed Web of Science ®Google Scholar
• Burtscher M, Faulhaber M, Flatz M, Likar R, Nachbauer W. Effects of short-term acclimatization to altitude (3200 m) on aerobic and anaerobic exercise performance. Int J Sports Med. 2006;27(8):629–635. doi:10.1055/s-2005-872823
   PubMed Web of Science ®Google Scholar
• Bärtsch P, Gibbs JS. Effect of altitude on the heart and the lungs. Circulation. 2007;116(19):2191–2202. doi:10.1161/CIRCULATIONAHA.106.650796
   PubMed Web of Science ®Google Scholar
• Levine BD. Going high with heart disease: the effect of high altitude exposure in older individuals and patients with coronary artery disease. High Alt Med Biol. 2015;16(2):89–96. doi:10.1089/ham.2015.0043
   PubMed Web of Science ®Google Scholar
• Naeije R. Physiological adaptation of the cardiovascular system to high altitude. Prog Cardiovasc Dis. 2010;52(6):456–466. doi:10.1016/j.pcad.2010.03.004
   PubMed Web of Science ®Google Scholar
• Lenfant C, Sullivan K. Adaptation to high altitude. N Engl J Med. 1971;284(23):1298–1309. doi:10.1056/NEJM197106102842305
   PubMed Web of Science ®Google Scholar
• Zouboules SM, Lafave HC, O’Halloran KD, et al. Renal reactivity: acid-base compensation during incremental ascent to high altitude. J Physiol. 2018;596(24):6191–6203. doi:10.1113/JP276973
   PubMed Web of Science ®Google Scholar
• Swenson ER. Carbonic anhydrase inhibitors and high altitude illnesses. Subcell Biochem. 2014;75:361–386. doi:10.1007/978-94-007-7359-2_18
   PubMedGoogle Scholar
• Burtscher M, Philadelphy M, Gatterer H, et al. Physiological responses in humans acutely exposed to high altitude (3480 m): minute ventilation and oxygenation are predictive for the development of acute mountain sickness. High Alt Med Biol. 2019;20:192–197. doi:10.1089/ham.2018.0143
   PubMed Web of Science ®Google Scholar
• Levine BD, Zuckerman JH, deFilippi CR. Effect of high-altitude exposure in the elderly: the Tenth Mountain Division study. Circulation. 1997;96(4):1224–1232. doi:10.1161/01.cir.96.4.1224
   PubMed Web of Science ®Google Scholar
• Parati G, Bilo G, Faini A, et al. Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial. Eur Heart J. 2014;35(44):3113–3122. doi:10.1093/eurheartj/ehu275
   PubMed Web of Science ®Google Scholar
• Lhuissier FJ, Canouï‐Poitrine F, Richalet JP. Ageing and cardiorespiratory response to hypoxia. J Physiol. 2012;590(21):5461–5474. doi:10.1113/jphysiol.2012.238527
   PubMed Web of Science ®Google Scholar
• Horstman D, Weiskopf R, Jackson RE. Work capacity during 3-wk sojourn at 4300 m: effects of relative polycythemia. J Appl Physiol Respir Environ Exerc Physiol. 1980;49(2):311–318. doi:10.1152/jappl.1980.49.2.311
   PubMed Web of Science ®Google Scholar
• Burtscher M, Niedermeier M, Burtscher J, Pesta D, Suchy J, Strasser B. Preparation for endurance competitions at altitude: physiological, psychological, dietary and coaching aspects. a narrative review. Front Physiol. 2018;9:1504. doi:10.3389/fphys.2018.01504
   PubMed Web of Science ®Google Scholar
• Burtscher M, Philadelphy M, Burtscher J, Likar R. Sex-specific differences in blood pressure responses following acute high-altitude exposure. J Travel Med. 2021. doi:10.1093/jtm/taab035
   Web of Science ®Google Scholar
• Cymerman A, Reeves JT, Sutton JR, et al. Operation Everest II: maximal oxygen uptake at extreme altitude. J Appl Physiol (1985). 1989;66(5):2446–2453. doi:10.1152/jappl.1989.66.5.2446
   PubMed Web of Science ®Google Scholar
• Burtscher M, Nachbauer W, Baumgartl P, Philadelphy M. Benefits of training at moderate altitude versus sea level training in amateur runners. Eur J Appl Physiol Occup Physiol. 1996;74(6):558–563. doi:10.1007/bf02376773
   PubMed Web of Science ®Google Scholar
• Parati G, Agostoni P, Basnyat B, et al. Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: a joint statement by the European Society of Cardiology, the Council on Hypertension of the European Society of Cardiology, the European Society of Hypertension, the International Society of Mountain Medicine, the Italian Society of Hypertension and the Italian Society of Mountain Medicine. Eur Heart J. 2018;39(17):1546–1554. doi:10.1093/eurheartj/ehx720
   PubMed Web of Science ®Google Scholar
• Rimoldi SF, Sartori C, Seiler C, et al. High-altitude exposure in patients with cardiovascular disease: risk assessment and practical recommendations. Prog Cardiovasc Dis. 2010;52(6):512–524. doi:10.1016/j.pcad.2010.03.005
   PubMed Web of Science ®Google Scholar
• Higgins JP, Tuttle T, Higgins JA. Altitude and the heart: is going high safe for your cardiac patient? Am Heart J. 2010;159(1):25–32. doi:10.1016/j.ahj.2009.10.028
   PubMed Web of Science ®Google Scholar
• Faulhaber M, Flatz M, Gatterer H, Schobersberger W, Burtscher M. Prevalence of cardiovascular diseases among alpine skiers and hikers in the Austrian Alps. High Alt Med Biol. 2007;8(3):245–252. doi:10.1089/ham.2007.1005
   PubMed Web of Science ®Google Scholar
• Alexander JK. Coronary heart disease at altitude. Tex Heart Inst J. 1994;21(4):261–266.
   PubMed Web of Science ®Google Scholar
• Erdmann J, Sun KT, Masar P, Niederhauser H. Effects of exposure to altitude on men with coronary artery disease and impaired left ventricular function. Am J Cardiol. 1998;81(3):266–270. doi:10.1016/s0002-9149(97)00901-6
   PubMed Web of Science ®Google Scholar
• Hackett PH, Creagh CE, Grover RF, et al. High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med. 1980;302(19):1070–1073. doi:10.1056/NEJM198005083021907
   PubMed Web of Science ®Google Scholar
• Richalet JP, Chenivesse C, Larmignat P, Meille L. High altitude pulmonary edema, down syndrome, and obstructive sleep apneas. High Alt Med Biol. 2008;9(2):179–181. doi:10.1089/ham.2007.1062
   PubMed Web of Science ®Google Scholar
• Sartori C, Allemann Y, Trueb L, Delabays A, Nicod P, Scherrer U. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet. 1999;353(9171):2205–2207. doi:10.1016/S0140-6736(98)08352-4
   PubMed Web of Science ®Google Scholar
• Lichtblau M, Saxer S, Latshang TD, et al. Altitude travel in patients with pulmonary hypertension: randomized pilot-trial evaluating nocturnal oxygen therapy. Front Med (Lausanne). 2020;7:502. doi:10.3389/fmed.2020.00502
   PubMed Web of Science ®Google Scholar
• Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA. 2006;296(24):2954–2958. doi:10.1001/jama.296.24.2954
   PubMed Web of Science ®Google Scholar
• Scherrer U, Allemann Y, Jayet PY, Rexhaj E, Sartori C. High altitude, a natural research laboratory for the study of cardiovascular physiology and pathophysiology. Prog Cardiovasc Dis. 2010;52(6):451–455. doi:10.1016/j.pcad.2010.02.002
   PubMed Web of Science ®Google Scholar
• Harinck E, Hutter PA, Hoorntje TM, et al. Air travel and adults with cyanotic congenital heart disease. Circulation. 1996;93(2):272–276. doi:10.1161/01.cir.93.2.272
   PubMed Web of Science ®Google Scholar
• Alexander JK. Coronary problems associated with altitude and air travel. Cardiol Clin. 1995;13(2):271–278.
   PubMedGoogle Scholar
• Donegani E, Hillebrandt D, Windsor J, et al. Pre-existing cardiovascular conditions and high altitude travel. Consensus statement of the Medical Commission of the Union Internationale des Associations d’Alpinisme (UIAA MedCom) Travel Medicine and Infectious Disease. Travel Med Infect Dis. 2014;12(3):237–252. doi:10.1016/j.tmaid.2014.02.004
   PubMedGoogle Scholar
• Schmid JP, Noveanu M, Gaillet R, Hellige G, Wahl A, Saner H. Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease. Heart. 2006;92(7):921–925. doi:10.1136/hrt.2005.072520
   PubMed Web of Science ®Google Scholar
• Agostoni P, Cattadori G, Guazzi M, et al. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure. Am J Med. 2000;109(6):450–455. doi:10.1016/s0002-9343(00)00532-5
   PubMed Web of Science ®Google Scholar
• Agostoni P. Considerations on safety and treatment of patients with chronic heart failure at high altitude. High Alt Med Biol. 2013;14(2):96–100. doi:10.1089/ham.2012.1117
   PubMed Web of Science ®Google Scholar
• Savonitto S, Cardellino G, Doveri G, et al. Effects of acute exposure to altitude (3460 m) on blood pressure response to dynamic and isometric exercise in men with systemic hypertension. Am J Cardiol. 1992;70(18):1493–1497. doi:10.1016/0002-9149(92)90308-l
   PubMed Web of Science ®Google Scholar
• Winkler L, Lhuissier FJ, Richalet JP. Systemic blood pressure at exercise in hypoxia in hypertensive and normotensive patients. J Hypertens. 2017;35(12):2402–2410. doi:10.1097/HJH.0000000000001479
   PubMed Web of Science ®Google Scholar
• Lyamina NP, Lyamina SV, Senchiknin VN, Mallet RT, Downey HF, Manukhina EB. Normobaric hypoxia conditioning reduces blood pressure and normalizes nitric oxide synthesis in patients with arterial hypertension. J Hypertens. 2011;29(11):2265–2272. doi:10.1097/HJH.0b013e32834b5846
   PubMed Web of Science ®Google Scholar
• Keyes LE, Sallade TD, Duke C, et al. Blood pressure and altitude: an observational cohort study of hypertensive and nonhypertensive himalayan trekkers in Nepal. High Alt Med Biol. 2017;18(3):267–277. doi:10.1089/ham.2017.0001
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005;62(10):1556–1560. doi:10.1001/archneur.62.10.1556
   PubMed Web of Science ®Google Scholar
• Broce IJ, Tan CH, Fan CC, et al. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease. Acta Neuropathol. 2019;137(2):209–226. doi:10.1007/s00401-018-1928-6
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64(2):277–281. doi:10.1212/01.WNL.0000149519.47454.F2
   PubMed Web of Science ®Google Scholar
• Rabin JS, Schultz AP, Hedden T, et al. Interactive associations of vascular risk and β-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain Study. JAMA Neurol. 2018;75(9):1124–1131. doi:10.1001/jamaneurol.2018.1123
   PubMed Web of Science ®Google Scholar
• Fiuza-Luces C, Santos-Lozano A, Joyner M, et al. Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat Rev Cardiol. 2018;15(12):731–743. doi:10.1038/s41569-018-0065-1
   PubMed Web of Science ®Google Scholar
• Toth P, Tarantini S, Csiszar A, Ungvari Z. Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. Am J Physiol Heart Circ Physiol. 2017;312(1):H1–h20. doi:10.1152/ajpheart.00581.2016
   PubMed Web of Science ®Google Scholar
• Asmaro D, Mayall J, Ferguson S. Cognition at altitude: impairment in executive and memory processes under hypoxic conditions. Aviat Space Environ Med. 2013;84(11):1159–1165. doi:10.3357/asem.3661.2013
   PubMedGoogle Scholar
• Bonnon M, Noël-Jorand MC, Therme P. Psychological changes during altitude hypoxia. Aviat Space Environ Med. 1995;66(4):330–335.
   PubMedGoogle Scholar
• Griva K, Stygall J, Wilson MH, et al. Caudwell Xtreme Everest: a prospective study of the effects of environmental hypoxia on cognitive functioning. PLoS One. 2017;12(3):e0174277. doi:10.1371/journal.pone.0174277
   PubMed Web of Science ®Google Scholar
• Nation DA, Bondi MW, Gayles E, Delis DC. Mechanisms of memory dysfunction during high altitude hypoxia training in military aircrew. J Int Neuropsychol Soc. 2017;23(1):1–10. doi:10.1017/s1355617716000965
   PubMed Web of Science ®Google Scholar
• Pagani M, Ravagnan G, Salmaso D. Effect of acclimatisation to altitude on learning. Cortex. 1998;34(2):243–251. doi:10.1016/S0010-9452(08)70751-2
   PubMed Web of Science ®Google Scholar
• Pelamatti G, Pascotto M, Semenza C. Verbal free recall in high altitude: proper names vs common names. Cortex. 2003;39(1):97–103. doi:10.1016/S0010-9452(08)70077-7
   PubMed Web of Science ®Google Scholar
• Nelson M. Psychological testing at high altitudes. Aviat Space Environ Med. 1982;53:122–126.
   PubMedGoogle Scholar
• de Aquino Lemos V, Antunes HK, Dos Santos RV, Lira FS, Tufik S, de Mello MT. High altitude exposure impairs sleep patterns, mood, and cognitive functions. Psychophysiology. 2012;49(9):1298–1306. doi:10.1111/j.1469-8986.2012.01411.x
   PubMed Web of Science ®Google Scholar
• Wilson MH, Newman S, Imray CH. The cerebral effects of ascent to high altitudes. Lancet Neurol. 2009;8(2):175–191. doi:10.1016/S1474-4422(09)70014-6
   PubMed Web of Science ®Google Scholar
• Hur T. Parkinsonism after climbing high amplitude mountain: a case report. J Neurol Sci. 2015;357:e270. doi:10.1016/j.jns.2015.08.948
   PubMed Web of Science ®Google Scholar
• Swaminath PV, Ragothaman M, Muthane UB, Udupa SA, Rao SL, Govindappa SS. Parkinsonism and personality changes following an acute hypoxic insult during mountaineering. Movement Disorders. 2006;21(8):1296–1297. doi:10.1002/mds.20941
   PubMed Web of Science ®Google Scholar
• Park K, Yang KI. Delayed parkinsonism following high mountain climbing: a case report. Neurology Asia. 2013;18(1):99–101.
   Web of Science ®Google Scholar
• Litch JA, Bishop RA. High-altitude global amnesia. Wilderness Environ Med. 2000;11(1):25–28. doi:10.1580/1080-6032(2000)011[0025:haga]2.3.co;2
   PubMed Web of Science ®Google Scholar
• Imray CH, Myers SD, Pattinson KT, et al. Effect of exercise on cerebral perfusion in humans at high altitude. J Appl Physiol (1985). 2005;99(2):699–706. doi:10.1152/japplphysiol.00973.2004
   PubMed Web of Science ®Google Scholar
• Sanborn MR, Edsell ME, Kim MN, et al. Cerebral hemodynamics at altitude: effects of hyperventilation and acclimatization on cerebral blood flow and oxygenation. Wilderness Environ Med. 2015;26(2):133–141. doi:10.1016/j.wem.2014.10.001
   PubMed Web of Science ®Google Scholar
• Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:1–16. doi:10.1038/s41580-019-0188-1
   PubMed Web of Science ®Google Scholar
• Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15(1):551–578. doi:10.1146/annurev.cellbio.15.1.551
   PubMed Web of Science ®Google Scholar
• Leonard MO, Kieran NE, Howell K, et al. Reoxygenation‐specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia‐reperfusion injury. FASEB J. 2006;20(14):2624–2626. doi:10.1096/fj.06-5097fje
   PubMed Web of Science ®Google Scholar
• Lendahl U, Lee KL, Yang H, Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet. 2009;10(12):821–832. doi:10.1038/nrg2665
   PubMed Web of Science ®Google Scholar
• Mela L, Goodwin CW, Miller LD. In vivo control of mitochondrial enzyme concentrations and activity by oxygen. Am J Physiol. 1976;231(6):1811–1816. doi:10.1152/ajplegacy.1976.231.6.1811
   PubMedGoogle Scholar
• Zhuang J-G, Zhou Z-N. Protective effects of intermittent hypoxic adaptation on myocardium and its mechanisms. Neurosignals. 1999;8(4–5):316–322. doi:10.1159/000014602
   Google Scholar
• Almohanna AM, Wray S. Hypoxic conditioning in blood vessels and smooth muscle tissues: effects on function, mechanisms, and unknowns. Am J Physiol Heart Circulatory Physiol. 2018;315(4):H756–H770. doi:10.1152/ajpheart.00725.2017
   PubMed Web of Science ®Google Scholar
• Bernaudin M, Nedelec A-S, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cerebral Blood Flow Metab. 2002;22(4):393–403. doi:10.1097/00004647-200204000-00003
   PubMed Web of Science ®Google Scholar
• Burtscher J, Maglione V, Di Pardo A, Millet GP, Schwarzer C, Zangrandi LA. Rationale for hypoxic and chemical conditioning in huntington’s disease. Int J Mol Sci. 2021;22:582. doi:10.3390/ijms22020582
   PubMed Web of Science ®Google Scholar
• Teppema LJ, Dahan A. The ventilatory response to hypoxia in mammals: mechanisms, measurement, and analysis. Physiol Rev. 2010;90(2):675–754. doi:10.1152/physrev.00012.2009
   PubMed Web of Science ®Google Scholar
• Serebrovskaya TV, Manukhina EB, Smith ML, Downey HF, Mallet RT. Intermittent hypoxia: cause of or therapy for systemic hypertension? Exp Biol Med. 2008;233(6):627–650. doi:10.3181/0710-MR-267
   Web of Science ®Google Scholar
• Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell. 1997;89(1):9–12. doi:10.1016/S0092-8674(00)80176-2
   PubMed Web of Science ®Google Scholar
• Lourenço CF, Ledo A, Barbosa RM, Laranjinha J. Neurovascular-neuroenergetic coupling axis in the brain: master regulation by nitric oxide and consequences in aging and neurodegeneration. Free Radic Biol Med. 2017;108:668–682. doi:10.1016/j.freeradbiomed.2017.04.026
   PubMed Web of Science ®Google Scholar
• Feddersen B, Neupane P, Thanbichler F, et al. Regional differences in the cerebral blood flow velocity response to hypobaric hypoxia at high altitudes. J Cereb Blood Flow Metab. 2015;35(11):1846–1851. doi:10.1038/jcbfm.2015.142
   PubMed Web of Science ®Google Scholar
• LaManna JC, Vendel LM, Farrell RM. Brain adaptation to chronic hypobaric hypoxia in rats. J Appl Physiol. 1992;72(6):2238–2243. doi:10.1152/jappl.1992.72.6.2238
   PubMed Web of Science ®Google Scholar
• LaManna JC, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. J Exp Biol. 2004;207(Pt 18):3163–3169. doi:10.1242/jeb.00976
   PubMed Web of Science ®Google Scholar
• Boero JA, Ascher J, Arregui A, Rovainen C, Woolsey TA. Increased brain capillaries in chronic hypoxia. J Appl Physiol. 1999;86(4):1211–1219. doi:10.1152/jappl.1999.86.4.1211
   PubMed Web of Science ®Google Scholar
• De Strooper B, Karran E. The cellular phase of Alzheimer’s disease. Cell. 2016;164(4):603–615. doi:10.1016/j.cell.2015.12.056
   PubMed Web of Science ®Google Scholar
• Navarrete-Opazo A, Mitchell GS. Therapeutic potential of intermittent hypoxia: a matter of dose. Am J Physiol Regul Integr Comp Physiol. 2014;307(10):R1181–R1197. doi:10.1152/ajpregu.00208.2014
   PubMed Web of Science ®Google Scholar
• Liu X, Xu D, Hall JR, et al. Enhanced cerebral perfusion during brief exposures to cyclic intermittent hypoxemia. J Appl Physiol (1985). 2017;123(6):1689–1697. doi:10.1152/japplphysiol.00647.2017
   PubMed Web of Science ®Google Scholar
• Iwamoto E, Hanson BE, Bock JM, Casey DP. Intermittent hypoxia enhances shear-mediated dilation of the internal carotid artery in young adults. J Appl Physiol. 2020;129(3):603–611. doi:10.1152/japplphysiol.00274.2020
   PubMed Web of Science ®Google Scholar
• Kalaria RN, Spoors L, Laude EA, et al. Hypoxia of sleep apnoea: cardiopulmonary and cerebral changes after intermittent hypoxia in rats. Respir Physiol Neurobiol. 2004;140(1):53–62. doi:10.1016/j.resp.2004.01.003
   PubMed Web of Science ®Google Scholar
• Chávez JC, Agani F, Pichiule P, LaManna JC. Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. J Appl Physiol (1985). 2000;89(5):1937–1942. doi:10.1152/jappl.2000.89.5.1937
   PubMed Web of Science ®Google Scholar
• Bayer U, Likar R, Pinter G, et al. Intermittent hypoxic–hyperoxic training on cognitive performance in geriatric patients. Alzheimer’s & Dementia. 2017;3(1):114–122.
   Google Scholar
• Schega L, Peter B, Törpel A, Mutschler H, Isermann B, Hamacher D. Effects of intermittent hypoxia on cognitive performance and quality of life in elderly adults: a pilot study. Gerontology. 2013;59(4):316–323. doi:10.1159/000350927
   PubMed Web of Science ®Google Scholar
• Schega L, Peter B, Brigadski T, et al. Effect of intermittent normobaric hypoxia on aerobic capacity and cognitive function in older people. J Sci Med Sport. 2016;19(11):941–945. doi:10.1016/j.jsams.2016.02.012
   PubMed Web of Science ®Google Scholar
• Serebrovska ZO, Serebrovska TV, Kholin VA, et al. Intermittent hypoxia-hyperoxia training improves cognitive function and decreases circulating biomarkers of alzheimer’s disease in patients with mild cognitive impairment: a Pilot Study. Int J Mol Sci. 2019;20(21):5405. doi:10.3390/ijms20215405
   PubMed Web of Science ®Google Scholar
• Wang H, Shi X, Schenck H, et al. Intermittent hypoxia training for treating mild cognitive impairment: a Pilot Study. Am J Alzheimers Dis Other Demen. 2020;35:1533317519896725. doi:10.1177/1533317519896725
   Web of Science ®Google Scholar
• Baillieul S, Chacaroun S, Doutreleau S, Detante O, Pépin JL, Verges S. Hypoxic conditioning and the central nervous system: a new therapeutic opportunity for brain and spinal cord injuries? Exp Biol Med. 2017;242(11):1198–1206. doi:10.1177/1535370217712691
   PubMed Web of Science ®Google Scholar
• Manukhina EB, Downey HF, Shi X, Mallet RT. Intermittent hypoxia training protects cerebrovascular function in Alzheimer’s disease. Exp Biol Med (Maywood). 2016;241(12):1351–1363. doi:10.1177/1535370216649060
   PubMed Web of Science ®Google Scholar
• Manukhina EB, Goryacheva AV, Barskov IV, et al. Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer’s disease by adaptation to hypoxia. Neurosci Behav Physiol. 2010;40(7):737–743. doi:10.1007/s11055-010-9320-6
   PubMedGoogle Scholar
• Correia SC, Machado NJ, Alves MG, Oliveira PF, Moreira PI. Intermittent hypoxic conditioning rescues cognition and mitochondrial bioenergetic profile in the triple transgenic mouse model of Alzheimer’s Disease. Int J Mol Sci. 2021;22(1):461. doi:10.3390/ijms22010461
   PubMed Web of Science ®Google Scholar
• Belikova MV, Kolesnikova EE, Serebrovskaya TV. Intermittent hypoxia and experimental Parkinson’s disease. Intermittent Hypoxia Human Dis. 2012;147–153.
   Google Scholar
• Ma H, Zhang D, Li X, Ma H, Wang N, Wang Y. Long-term exposure to high altitude attenuates verbal and spatial working memory: evidence from an event-related potential study. Brain Behav. 2019;9(4):e01256. doi:10.1002/brb3.1256
   PubMed Web of Science ®Google Scholar
• Hill CM, Dimitriou D, Baya A, et al. Cognitive performance in high-altitude Andean residents compared with low-altitude populations: from childhood to older age. Neuropsychology. 2014;28(5):752. doi:10.1037/neu0000065
   PubMed Web of Science ®Google Scholar
• Richardson C, Hogan AM, Bucks RS, et al. Neurophysiological evidence for cognitive and brain functional adaptation in adolescents living at high altitude. Clin Neurophysiol. 2011;122(9):1726–1734. doi:10.1016/j.clinph.2011.02.001
   PubMed Web of Science ®Google Scholar
• Calbet JA, Boushel R, Radegran G, Sondergaard H, Wagner PD, Saltin B. Determinants of maximal oxygen uptake in severe acute hypoxia. Am J Physiol Regul Integr Comp Physiol. 2003;284(2):R291–303. doi:10.1152/ajpregu.00155.2002
   PubMed Web of Science ®Google Scholar
• Wehrlin JP, Hallen J. Linear decrease in.VO2max and performance with increasing altitude in endurance athletes. Eur J Appl Physiol Occup Physiol. 2006;96(4):404–412. doi:10.1007/s00421-005-0081-9
   PubMed Web of Science ®Google Scholar
• Saugy JJ, Rupp T, Faiss R, Lamon A, Bourdillon N, Millet GP. Cycling time trial is more altered in hypobaric than normobaric hypoxia. Med Sci Sports Exerc. 2016;48(4):680–688. doi:10.1249/MSS.0000000000000810
   PubMed Web of Science ®Google Scholar
• Richalet JP. CrossTalk opposing view: barometric pressure, independent of P O 2, is not the forgotten parameter in altitude physiology and mountain medicine. J Physiol. 2020;598(5):897–899. doi:10.1113/JP279160
   PubMed Web of Science ®Google Scholar
• Millet GP, Debevec T. CrossTalk proposal: barometric pressure, independent of P O 2, is the forgotten parameter in altitude physiology and mountain medicine. J Physiol. 2020;598(5):893–896. doi:10.1113/JP278673
   PubMed Web of Science ®Google Scholar
• Richalet JP, Kacimi R, Antezana AM. The control of cardiac chronotropic function in hypobaric hypoxia. Int J Sports Med. 1992;13(Suppl 1):S22–4. doi:10.1055/s-2007-1024582
   PubMedGoogle Scholar
• Mourot L. Limitation of Maximal Heart Rate in Hypoxia: mechanisms and Clinical Importance. Front Physiol. 2018;9:972. doi:10.3389/fphys.2018.00972
   PubMed Web of Science ®Google Scholar
• Fukuda T, Maegawa T, Matsumoto A, et al. Effects of acute hypoxia at moderate altitude on stroke volume and cardiac output during exercise. Int Heart J. 2010;51(3):170–175. doi:10.1536/ihj.51.170
   PubMed Web of Science ®Google Scholar
• Gore CJ, Hahn AG, Scroop GC, et al. Increased arterial desaturation in trained cyclists during maximal exercise at 580 m altitude. Research Support, Non-U.S. Gov’t. J Appl Physiol. 1996;80(6):2204–2210. doi:10.1152/jappl.1996.80.6.2204
   PubMed Web of Science ®Google Scholar
• Mourot L, Millet GP. Is maximal heart rate decrease similar between normobaric versus hypobaric hypoxia in trained and untrained subjects? High Alt Med Biol. 2019;20(1):94–98. doi:10.1089/ham.2018.0104
   PubMed Web of Science ®Google Scholar
• Casillas JM, Gudjoncik A, Gremeaux V, Aulagne J, Besson D, Laroche D. Assessment tools for personalizing training intensity during cardiac rehabilitation: literature review and practical proposals. Ann Phys Rehabil Med. 2017;60(1):43–49. doi:10.1016/j.rehab.2016.01.011
   PubMed Web of Science ®Google Scholar
• Netzer NC, Chytra R, Kupper T. Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia. Sleep Breathing. 2008;12(2):129–134. doi:10.1007/s11325-007-0149-3
   PubMed Web of Science ®Google Scholar
• Kong Z, Zang Y, Hu Y. Normobaric hypoxia training causes more weight loss than normoxia training after a 4-week residential camp for obese young adults. Sleep Breathing. 2014;18(3):591–597. doi:10.1007/s11325-013-0922-4
   PubMed Web of Science ®Google Scholar
• Casey DP, Joyner MJ. Compensatory vasodilatation during hypoxic exercise: mechanisms responsible for matching oxygen supply to demand. J Physiol. 2012;590(24):6321–6326. doi:10.1113/jphysiol.2012.242396
   PubMed Web of Science ®Google Scholar
• Casey DP, Madery BD, Curry TB, Eisenach JH, Wilkins BW, Joyner MJ. Nitric oxide contributes to the augmented vasodilatation during hypoxic exercise. J Physiol. 2010;588(Pt 2):373–385. doi:10.1113/jphysiol.2009.180489
   PubMed Web of Science ®Google Scholar
• Casey DP, Curry TB, Wilkins BW, Joyner MJ. Nitric oxide-mediated vasodilation becomes independent of beta-adrenergic receptor activation with increased intensity of hypoxic exercise. J Appl Physiol (1985). 2011;110(3):687–694. doi:10.1152/japplphysiol.00787.2010
   PubMed Web of Science ®Google Scholar
• Montero D, Lundby C. Effects of exercise training in hypoxia versus normoxia on vascular health. Sports Med. 2016;46(11):1725–1736. doi:10.1007/s40279-016-0570-5
   PubMed Web of Science ®Google Scholar
• Kleinnibbelink G, Stens NA, Fornasiero A, et al. The acute and chronic effects of high-intensity exercise in hypoxia on blood pressure and post-exercise hypotension: a randomized cross-over trial. Medicine (Baltimore). 2020;99(39):e22411. doi:10.1097/MD.0000000000022411
   PubMed Web of Science ®Google Scholar
• Jefferson JA, Simoni J, Escudero E, et al. Increased oxidative stress following acute and chronic high altitude exposure. High Alt Med Biol. 2004;5(1):61–69. doi:10.1089/152702904322963690
   PubMed Web of Science ®Google Scholar
• Magalhães J, Ascensão A, Viscor G, et al. Oxidative stress in humans during and after 4 hours of hypoxia at a simulated altitude of 5500 m. Aviat Space Environ Med. 2004;75(1):16–22.
   PubMedGoogle Scholar
• Mrakic-Sposta S, Gussoni M, Dellanoce C, et al. Effects of acute and sub-acute hypobaric hypoxia on oxidative stress: a field study in the Alps. Eur J Appl Physiol. 2021;121(1):297–306. doi:10.1007/s00421-020-04527-x
   PubMed Web of Science ®Google Scholar
• Jain K, Suryakumar G, Prasad R, Ganju L. Upregulation of cytoprotective defense mechanisms and hypoxia-responsive proteins imparts tolerance to acute hypobaric hypoxia. High Alt Med Biol. 2013;14(1):65–77. doi:10.1089/ham.2012.1064
   PubMed Web of Science ®Google Scholar
• Singh M, Thomas P, Shukla D, Tulsawani R, Saxena S, Bansal A. Effect of subchronic hypobaric hypoxia on oxidative stress in rat heart. Appl Biochem Biotechnol. 2013;169(8):2405–2419. doi:10.1007/s12010-013-0141-2
   PubMed Web of Science ®Google Scholar
• Herrera EA, Farías JG, González-Candia A, Short SE, Carrasco-Pozo C, Castillo RL. Ω3 Supplementation and intermittent hypobaric hypoxia induce cardioprotection enhancing antioxidant mechanisms in adult rats. Mar Drugs. 2015;13(2):838–860. doi:10.3390/md13020838
   PubMed Web of Science ®Google Scholar
• Aguilar M, González-Candia A, Rodríguez J, et al. Mechanisms of cardiovascular protection associated with intermittent hypobaric hypoxia exposure in a rat model: role of oxidative stress. Int J Mol Sci. 2018;19:366. doi:10.3390/ijms19020366
   PubMed Web of Science ®Google Scholar
• Guo HC, Zhang Z, Zhang LN, et al. Chronic intermittent hypobaric hypoxia protects the heart against ischemia/reperfusion injury through upregulation of antioxidant enzymes in adult guinea pigs. Acta Pharmacol Sin. 2009;30(7):947–955. doi:10.1038/aps.2009.57
   PubMed Web of Science ®Google Scholar
• Karar J, Dolt KS, Mishra MK, Arif E, Javed S, Pasha MA. Expression and functional activity of pro-oxidants and antioxidants in murine heart exposed to acute hypobaric hypoxia. FEBS Lett. 2007;581(24):4577–4582. doi:10.1016/j.febslet.2007.08.044
   PubMed Web of Science ®Google Scholar
• Estrada JA, Williams AG, Sun J, et al. δ-Opioid receptor (DOR) signaling and reactive oxygen species (ROS) mediate intermittent hypoxia induced protection of canine myocardium. Basic Res Cardiol. 2016;111(2):17. doi:10.1007/s00395-016-0538-5
   PubMed Web of Science ®Google Scholar
• He F, Ru X, Wen T. NRF2, a Transcription Factor for Stress Response and Beyond. Int J Mol Sci. 2020;21. doi:10.3390/ijms21134777.
   Web of Science ®Google Scholar
• Shanmugam G, Narasimhan M, Conley RL, et al. Chronic endurance exercise impairs cardiac structure and function in middle-aged mice with impaired Nrf2 Signaling. Front Physiol. 2017;8:268. doi:10.3389/fphys.2017.00268
   PubMed Web of Science ®Google Scholar
• Stockmann C, Fandrey J. Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression. Clin Exp Pharmacol Physiol. 2006;33(10):968–979. doi:10.1111/j.1440-1681.2006.04474.x
   PubMed Web of Science ®Google Scholar
• Belaidi E, Morand J, Gras E, Pépin JL, Godin-Ribout D. Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications. Pharmacol Ther. 2016;168:1–11. doi:10.1016/j.pharmthera.2016.07.010
   PubMed Web of Science ®Google Scholar
• Huang YT, Liu CH, Yang YC, et al. ROS- and HIF1α-dependent IGFBP3 upregulation blocks IGF1 survival signaling and thereby mediates high-glucose-induced cardiomyocyte apoptosis. J Cell Physiol. 2019;234:13557–13570. doi:10.1002/jcp.28034
   PubMed Web of Science ®Google Scholar
• Jiang L, Zeng H, Ni L, et al. HIF-1α preconditioning potentiates antioxidant activity in ischemic injury: the role of sequential administration of dihydrotanshinone I and protocatechuic aldehyde in cardioprotection. Antioxid Redox Signal. 2019;31:227–242. doi:10.1089/ars.2018.7624
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. 2007;2007(407):cm8. doi:10.1126/stke.4072007cm8
   PubMedGoogle Scholar
• Sugden PH. An overv iew of endothelin signaling in the cardiac myocyte. J Mol Cell Cardiol. 2003;35:871–886. doi:10.1016/s0022-2828(03)00153-6
   PubMed Web of Science ®Google Scholar
• Suzuki YJ. Growth factor signaling for cardioprotection against oxidative stress-induced apoptosis. Antioxid Redox Signal. 2003;5:741–749. doi:10.1089/152308603770380043
   PubMed Web of Science ®Google Scholar
• Ryou MG, Flaherty DC, Hoxha B, et al. Pyruvate-fortified cardioplegia evokes myocardial erythropoietin signaling in swine undergoing cardiopulmonary bypass. Am J Physiol Heart Circ Physiol. 2009;297(5):H1914–22. doi:10.1152/ajpheart.01213.2008
   PubMed Web of Science ®Google Scholar
• Ryou MG, Liu R, Ren M, Sun J, Mallet RT, Yang SH. Pyruvate protects the brain against ischemia-reperfusion injury by activating the erythropoietin signaling pathway. Stroke. 2012;43(4):1101–1107. doi:10.1161/STROKEAHA.111.620088
   PubMed Web of Science ®Google Scholar
• Chen SM, Li YG, Zhang HX, et al. Hypoxia-inducible factor-1alpha induces the coronary collaterals for coronary artery disease. Coron Artery Dis. 2008;19(3):173–179. doi:10.1097/MCA.0b013e3282fa4b2c
   PubMed Web of Science ®Google Scholar
• Piperno A, Galimberti S, Mariani R, et al. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood. 2011;117(10):2953–2959. doi:10.1182/blood-2010-08-299859
   PubMed Web of Science ®Google Scholar
• Lundby AK, Keiser S, Siebenmann C, Schäffer L, Lundby C. Kidney-synthesized erythropoietin is the main source for the hypoxia-induced increase in plasma erythropoietin in adult humans. Eur J Appl Physiol. 2014;114(6):1107–1111. doi:10.1007/s00421-014-2844-7
   PubMed Web of Science ®Google Scholar
• Sasaki H, Fukuda S, Otani H, et al. Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction. J Mol Cell Cardiol. 2002;34(3):335–348. doi:10.1006/jmcc.2001.1516
   PubMed Web of Science ®Google Scholar
• Aghajanian A, Zhang H, Buckley BK, Wittchen ES, Ma WY, Faber JE. Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart. J Mol Cell Cardiol. 2021;150:1–11. doi:10.1016/j.yjmcc.2020.09.015
   PubMed Web of Science ®Google Scholar
• Morganti A, Giussani M, Sala C, et al. Effects of exposure to high altitude on plasma endothelin-1 levels in normal subjects. J Hypertens. 1995;13:859–865. doi:10.1097/00004872-199508000-00006
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yang S, Luo Y, et al. A randomly-controlled study on the cardiac function at he early stage of return to the plains after short-term exposure to high altitude. PLoS One. 2012;7:e31097. doi:10.1371/journal.pone.0031097
   PubMed Web of Science ®Google Scholar
• Kitta K, Clément SA, Remeika J, Blumberg JB, Suzuki YJ. Endothelin-1 induces phosphorylation of GATA-4 transcription factor in the HL-1 atrial-muscle cell line. Biochem J. 2001;359:375–380. doi:10.1042/0264-6021:3590375
   PubMed Web of Science ®Google Scholar
• Hautala N, Tenhunen O, Szokodi I, Ruskoaho H. Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways. Pflügers Arch. 2002;443:362–369. doi:10.1007/s004240100699
   PubMed Web of Science ®Google Scholar
• Verma S, Rao V, Weisel RD, et al. Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells. J Surg Res. 2004;119:66–71. doi:10.1016/j.jss.2003.10.011
   PubMed Web of Science ®Google Scholar
• Kagamu H, Suzuki T, Arakawa M, Mitsui Y. Low oxygen enhances endothelin-1 (ET-1) production and responsiveness to ET-1 in cultured cardiac myocytes. Biochem Biophys Res Commun. 1994;202:1612–1618. doi:10.1006/bbrc.1994.2117
   PubMed Web of Science ®Google Scholar
• Kakinuma Y, Miyauchi T, Yuki K, Murakoshi N, Goto K, Yamaguchi I. Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1α induced for impaired myocardial energy metabolism. Circulation. 2001;103:2387–2394. doi:10.1161/01.cir.103.19.2387
   PubMed Web of Science ®Google Scholar
• Takanashi M, Miyauchi T, Kakinuma Y, Goto K, Yamaguchi I. Establishment of hypoxia inducible factor-1α overexpressing cells that produce endothelin-1. J Cardiovasc Pharmacol. 2004;44:S268–73. doi:10.1097/01.fjc.0000166282.01034.8f
   PubMed Web of Science ®Google Scholar
• Piuhola J, Kerkelä R, Keenan JI, Hampton MB, Richards AM, Pemberton CJ. Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury. Clin Sci (Lond). 2008;114:293–304. doi:10.1042/CS20070229
   PubMed Web of Science ®Google Scholar
• Ren A, Yan X, Lu H, et al. Antagonism of endothelin-1 inhibits hypoxia-induced apoptosis in cardiomyocytes. Can J Physiol Pharmacol. 2008;86:536–540. doi:10.1139/Y08-051
   PubMed Web of Science ®Google Scholar
• Dhar P, Sharma VK, Hota KB, et al. Autonomic cardiovascular responses in acclimatized lowlanders on prolonged stay at high altitude: a longitudinal follow up study. PLoS One. 2014;9(1):e84274. doi:10.1371/journal.pone.0084274
   PubMed Web of Science ®Google Scholar
• Li Y, Shi L, Wu N, et al. [Effects of hyperbaric oxygen preconditioning on human stress responses during acute exposure to high altitude]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2015;33(10):731–734.
   PubMedGoogle Scholar
• Dhar P, Sharma VK, Das SK, Barhwal K, Hota SK, Singh SB. Differential responses of autonomic function in sea level residents, acclimatized lowlanders at >3500 m and Himalayan high altitude natives at >3500 m: a cross-sectional study. Respir Physiol Neurobiol. 2018;254:40–48. doi:10.1016/j.resp.2018.04.002
   PubMed Web of Science ®Google Scholar
• Wu L, Tan JL, Wang ZH, et al. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. J Mol Cell Cardiol. 2015;81:150–161. doi:10.1016/j.yjmcc.2015.02.015
   PubMed Web of Science ®Google Scholar
• Mallet RT, Ryou MG, Williams AG, Howard L, Downey HF. β1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia. Basic Res Cardiol. 2006;101(5):436–446. doi:10.1007/s00395-006-0599-y
   PubMed Web of Science ®Google Scholar
• Müller FU, Lewin G, Baba HA, et al. Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J Biol Chem. 2005;280(8):6906–6914. doi:10.1074/jbc.M407864200
   PubMed Web of Science ®Google Scholar
• El Jamali A, Freund C, Rechner C, Scheidereit C, Dietz R, Bergmann MW. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta. FASEB J. 2004;18(10):1096–1098. doi:10.1096/fj.03-1054fje
   PubMedGoogle Scholar
• Tomita H, Nazmy M, Kajimoto K, Yehia G, Molina CA, Sadoshima J. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation. Circ Res. 2003;93(1):12–22. doi:10.1161/01.RES.0000079794.57578.F1
   PubMed Web of Science ®Google Scholar
• Schulte JS, Fehrmann E, Tekook MA, et al. Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes. Basic Res Cardiol. 2016;111(2):15. doi:10.1007/s00395-016-0532-y
   PubMed Web of Science ®Google Scholar
• ASA/JPL-Caltech. Aster Global Digital Elevation Map (GDEM). Available at: https://asterweb.jpl.nasa.gov/images/GDEM-10km-colorized.png. Accessed February 28, 2021.
   Google Scholar